Treatment for Severe Vitamin D Deficiency

Understanding the Severity

A vitamin D level of 5 ng/mL represents severe deficiency, placing the patient at significant risk for osteomalacia, secondary hyperparathyroidism, increased fracture risk, and excess mortality 2, 1
Severe deficiency is defined as levels below 10-12 ng/mL, which dramatically increases risk for nutritional rickets and osteomalacia 3
This level is associated with greater severity of secondary hyperparathyroidism, even in patients with chronic kidney disease 3

Administer cholecalciferol 50,000 IU once weekly for 12 weeks 1
The total cumulative dose over 12 weeks is 600,000 IU, which should raise 25(OH)D levels by approximately 40-70 nmol/L (16-28 ng/mL), bringing the level to at least 28-40 ng/mL 3
Take with the largest, fattiest meal of the day to maximize absorption, as vitamin D is fat-soluble and requires dietary fat for optimal intestinal uptake 3

Ensure adequate calcium intake of 1,000-1,500 mg daily from diet plus supplements if needed 3
Calcium supplements should be taken in divided doses of no more than 600 mg at once for optimal absorption, separated by at least 2 hours from the vitamin D dose 3
Check baseline serum calcium levels to rule out hypocalcemia before supplementation 3

Transition to maintenance therapy with 2,000 IU daily OR 50,000 IU twice monthly (equivalent to approximately 3,200 IU daily) 3, 1
The target 25(OH)D level is at least 30 ng/mL for optimal health benefits, particularly for anti-fracture efficacy 3
For patients over 60 years, maintenance doses of 800-1,000 IU daily are particularly important 1

Check serum calcium and phosphorus at 1 month after initiating vitamin D, then every 3 months during treatment 1
Recheck 25(OH)D levels at 3 months (after completing the loading phase) to confirm adequate response and allow levels to plateau 3, 1
If using intermittent dosing, measure levels just prior to the next scheduled dose 3

The American Journal of Kidney Diseases recommends using the same standard nutritional vitamin D replacement with cholecalciferol for patients with chronic kidney disease (CKD Stages 3-4) 1
CKD patients are at particularly high risk due to reduced sun exposure, dietary restrictions, urinary losses of 25(OH)D, and reduced endogenous synthesis 2, 1
Vitamin D insufficiency is present in 80-90% of elderly CKD patients 1

Daily doses up to 4,000 IU are generally safe for adults, with some evidence supporting up to 10,000 IU daily for several months without adverse effects 3, 1
Doses up to 10,000 IU daily have been used in advanced CKD patients for over 1 year without toxicity 1
The upper safety limit for 25(OH)D is 100 ng/mL 3
Vitamin D toxicity is exceptionally rare and typically only occurs with prolonged daily doses exceeding 10,000 IU or serum 25(OH)D levels above 100 ng/mL 3